Procter & Gamble (PG) has seen its stock rise 11.65% year-to-date, but this growth lags behind competitors like Clorox, Colgate-Palmolive, and Church & Dwight in the consumer staples sector. The company, under new CEO Shailesh Jejurikar, faces significant challenges including $900 million in tariff headwinds and projected fiscal 2026 organic sales growth of flat to 3%, lower than analyst expectations. Despite its premium valuation and status as a Dividend Aristocrat appealing to income investors, P&G’s growth outlook appears questionable due to these pressures and its underperformance compared to peers.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
P&G Rallies Under New CEO but Lags Rivals, Faces Tariff Challenges
Procter & Gamble (PG) has seen its stock rise 11.65% year-to-date, but this growth lags behind competitors like Clorox, Colgate-Palmolive, and Church & Dwight in the consumer staples sector. The company, under new CEO Shailesh Jejurikar, faces significant challenges including $900 million in tariff headwinds and projected fiscal 2026 organic sales growth of flat to 3%, lower than analyst expectations. Despite its premium valuation and status as a Dividend Aristocrat appealing to income investors, P&G’s growth outlook appears questionable due to these pressures and its underperformance compared to peers.